menu search

Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Officer

Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Officer
Industry veteran and prominent diabetes clinical development expert to oversee Biomea’s progressing clinical development of novel covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes Steve Morris, M.D., will transition to the role of Chief Development Officer, continuing to lead clinical development of Biomea’s oncology portfolio, including BMF-219, BMF-500 and research-stage assets REDWOOD […] The post Biomea Fusion Announces Appointment of Juan Pablo Frías, M.D. as Chief Medical Offi... Read More
Posted: Aug 31 2023, 12:30
Author Name: forextv
Views: 1116100

Search within

Pages Search Results: